Your browser doesn't support javascript.
loading
Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions.
Baumann, Niklas; Rösner, Thies; Jansen, J H Marco; Chan, Chilam; Marie Eichholz, Klara; Klausz, Katja; Winterberg, Dorothee; Müller, Kristina; Humpe, Andreas; Burger, Renate; Peipp, Matthias; Schewe, Denis M; Kellner, Christian; Leusen, Jeanette H W; Valerius, Thomas.
Affiliation
  • Baumann N; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Rösner T; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Jansen JHM; Immunotherapy Laboratory, Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Chan C; Immunotherapy Laboratory, Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Marie Eichholz K; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Klausz K; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Winterberg D; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Müller K; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Humpe A; Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, LMU Munich, Munich, Germany.
  • Burger R; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Peipp M; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Schewe DM; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Kellner C; Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, LMU Munich, Munich, Germany.
  • Leusen JHW; Immunotherapy Laboratory, Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Valerius T; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Cancer Sci ; 112(8): 3029-3040, 2021 Aug.
Article in En | MEDLINE | ID: mdl-34058788

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Immunologic / Antigens, Differentiation / Aminoacyltransferases / CD47 Antigen / Small Molecule Libraries / Antineoplastic Agents, Immunological / Neoplasms Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Cancer Sci Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Immunologic / Antigens, Differentiation / Aminoacyltransferases / CD47 Antigen / Small Molecule Libraries / Antineoplastic Agents, Immunological / Neoplasms Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Cancer Sci Year: 2021 Document type: Article